According to ESSA Pharma's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$38.82 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -C$45.65 Million | 17.59% |
2023 | -C$38.82 Million | -15.87% |
2022 | -C$46.14 Million | -16.52% |
2021 | -C$55.27 Million | 57.5% |
2020 | -C$35.1 Million | 109.01% |
2019 | -C$16.79 Million | 5.15% |
2018 | -C$15.97 Million | 62.81% |
2017 | -C$9.81 Million | 6.45% |
2016 | -C$9.22 Million | -43.02% |
2015 | -C$16.18 Million | 310.75% |
2014 | -C$3.94 Million |